Timing of response with venetoclax combination treatment in patients with newly diagnosed acute myeloid leukemia

Am J Hematol. 2022 Aug;97(8):E299-E303. doi: 10.1002/ajh.26600. Epub 2022 Jun 10.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Bridged Bicyclo Compounds, Heterocyclic* / therapeutic use
  • Humans
  • Leukemia, Myeloid, Acute* / diagnosis
  • Sulfonamides / therapeutic use

Substances

  • Bridged Bicyclo Compounds, Heterocyclic
  • Sulfonamides
  • venetoclax